VOLPI, Nicola.
 Symptomatic slow-acting drugs (SYSADOAs)/disease modifying anti-osteoarthrosis drugs (DMOADs) in the treatment of osteoarthrosis: what is the opinion of the different rheumatology/osteoarthritis societies in 2021?.
<strong>Medical Research Archives</strong>, [S.l.], v. 10, n. 1, jan. 2022.
ISSN 2375-1924.
Available at: &lt;<a href="https://esmed.org/MRA/mra/article/view/2676" target="_new">https://esmed.org/MRA/mra/article/view/2676</a>&gt;. Date accessed: 19 apr. 2024.
doi: <a href="https://doi.org/10.18103/mra.v10i1.2676">https://doi.org/10.18103/mra.v10i1.2676</a>.